- Home
- Primary Care
- MedX Weekly: FDA Approves Topical JAK Inhibitor for Hand Eczema, Obefazimod Hits UC Trial Milestone & More

1w2 min read
Medical Article
Hello, and a warm welcome to MedX, where we bring you the latest news and insights from the world of medicine. FDA Approves Topical Pan-JAK Inhibitor for Chronic Hand Eczema in Adults The U.S. Food and Drug Administration (FDA) has approved a topical pan-Janus kinase (JAK) inhibitor for the treatment of moderate-to-severe chronic hand eczema in ad
MedX Weekly: FDA Approves Topical JAK Inhibitor for Hand Eczema, Obefazimod Hits UC Trial Milestone & More
3534 Reached2 Comments
Similar Content

Single-incision Laparoscopy for Gastrostomy
407 Reached2 Comments1 Likes

Intestinal Obstruction and Ileocolic Fistula due to Gossypiboma
861 Reached30 Comments15 Likes

Female with History of Amenorrhoea
3095 Reached10 Comments11 Likes

Male Complaining of Bilateral Knee Pain and Gait Disturbance
840 Reached5 Comments1 Likes

Role and Importance of DHA in Cognitive Development
524 Reached1 Likes